Companion Animal Vaccines Market Report 2026

Companion Animal Vaccines Market Overview

• Companion Animal Vaccines market size has reached to $4.55 billion in 2025 • Expected to grow to $7.41 billion in 2030 at a compound annual growth rate (CAGR) of 10.3% • Growth Driver: Increasing Spending On Pet Healthcare Driving The Market Growth Due To Rising Pet Ownership And Humanization Trends • Market Trend: Innovative Vaccine Advancements Driving Preventive Care In Companion Animal Health • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Companion Animal Vaccines Market?

Companion animal vaccines are biological products designed to stimulate the immune system of pets, helping them develop protection against specific infectious diseases. They reduce the risk, severity, and spread of illnesses among animals and in shared human environments. Companion animal vaccines play a key role in preventive veterinary care by supporting animal health, meeting regulatory requirements, and minimizing the risk of zoonotic diseases. The main product types of companion animal vaccines include inactivated, live attenuated, recombinant, and other products. Inactivated refers to vaccines prepared from pathogens that have been killed or rendered non-infectious while retaining their ability to stimulate an immune response in companion animals. The animal framework includes feline, canine, avian, and other animal types and they are administered through oral, parenteral, and other routes of administration. They are categorized by material type such as killed or inactivated vaccines, modified-live vaccines (MLV), recombinant vaccines, and subunit and mRNA-based vaccines and they are distributed through veterinary hospitals, veterinary clinics, pharmacies and drug stores, and other distribution channels.

What Is The Companion Animal Vaccines Market Growth Forecast?

The companion animal vaccines market size is expected to see rapid growth in the next few years.It will grow to $7.41 billion by 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to increasing demand for personalized pet healthcare solutions, growth in pet insurance coverage driving vaccination uptake, rising investment in advanced recombinant and mRNA vaccine platforms, expansion of emerging market veterinary infrastructure, growing focus on zoonotic disease prevention and global health security.Major trends in the forecast period include increasing pet humanization driving higher vaccination compliance and preventive healthcare adoption, rising awareness of zoonotic disease transmission boosting routine immunization in companion animals, expansion of veterinary healthcare infrastructure and clinic networks improving vaccine accessibility, growing use of combination and multivalent vaccines to reduce multiple injections and improve compliance, strengthening regulatory mandates and pet travel requirements enforcing vaccination standards.

Global Companion Animal Vaccines Market Segmentation

1) By Product: Inactivated, Live Attenuated, Other Products 2) By Animal Type: Feline, Canine, Avian, Other Animal Types 3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration 4) By Material Type: Killed Or Inactivated Vaccines, Modified-Live Vaccines (MLV), Recombinant Vaccines, Subunit And mRNA-Based Vaccines 5) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores, Other Distribution Channels Subsegments: 1) By Inactivated: Killed Viral Vaccine, Killed Bacterial Vaccine, Toxoid Vaccine, Subunit Vaccine 2) By Live Attenuated: Modified Live Viral Vaccine, Modified Live Bacterial Vaccine, Chimeric Vaccine, Attenuated Parasite Vaccine 3) By Other Products: Combination Vaccine, Adjuvanted Vaccine, Autogenous Vaccine, Novel Platform Vaccine

What Is The Driver Of The Companion Animal Vaccines Market?

The increasing spending on pet healthcare is expected to propel the growth of the companion animal vaccines industry going forward.Pet healthcare spending refers to the total financial outlay by pet owners on veterinary services, preventive care, medications, and related health products for their companion animals.The increasing spending on pet healthcare due to the rising trend of pet humanization, where owners treat pets as family members, is driving growth as it encourages greater investment in preventive and routine veterinary care, including vaccinations, to support long-term animal well-being.The rising expenditure on pet healthcare directly fuels the demand for companion animal vaccines, as pet owners increasingly seek preventive solutions to protect their animals from infectious and life-threatening diseases.For instance, in March 2024, according to the American Pet Products Association (APPA), a US-based trade association for the pet industry, veterinary care and product sales in the United States rose from $35.9 billion in 2022 to $38.3 billion in 2023, reflecting an increase of $2.4 billion.Therefore, increasing spending on pet healthcare is driving the growth of the companion animal vaccines industry.

Key Players In The Global Companion Animal Vaccines Market

Major companies operating in the companion animal vaccines market are Boehringer Ingelheim International GmbH, Zoetis Inc., Ceva Santé Animale S. A., Virbac S. A., Phibro Animal Health Corporation, Neogen Corporation, Vetoquinol S. A., Norbrook Laboratories Limited, HIPRA S. A., Indian Immunologicals Limited, Vaxxinova International B. V., Bimeda Animal Health Limited, Laboratorios Calier S. A., Hester Biosciences Limited, ChoongAng Vaccine Laboratories Co. Ltd., Elanco Animal Health Incorporated, Bioveta a. s., CZ Veterinaria S. A., Intervet Inc. (Merck Animal Health), Brilliant Bio Pharma Private Limited, Durvet Inc., Kyoritsu Seiyaku Corporation

Global Companion Animal Vaccines Market Trends and Insights

Major companies operating in the companion animal vaccines market are focusing on developing innovative products such as injectable recombinant vaccines to enhance immunization effectiveness and improve administration flexibility. An injectable recombinant vaccine is a biologically engineered immunization that uses recombinant antigens to induce a targeted immune response in animals. For instance, in November 2025, Zoetis Services LLC, a US-based animal health company, launched Vanguard Recombishield. It is a non-adjuvanted, recombinant injectable vaccine that incorporates the pertactin protein to enable more precise immune system targeting while reducing adverse reactions during administration. It also offers a more comfortable and versatile vaccination approach, supporting improved compliance and effective prevention of respiratory infections in dogs.

What Are Latest Mergers And Acquisitions In The Companion Animal Vaccines Market?

In June 2023, Mars Inc., a US-based manufacturing company, acquired Heska Corp. for an amount of $1. 3 billion. This acquisition strengthens Mars Petcare's veterinary care capabilities and advances its commitment to improving pet health. Heska is now part of Mars Petcare's science and diagnostics division, including Antech Diagnostics. The integration enhances diagnostic services for veterinary professionals and pet owners, expanding access to advanced diagnostic technologies and accelerating research and development in veterinary healthcare. Heska Corp is a US-based veterinary services company that specializes in developing, manufacturing, and commercializing advanced veterinary diagnostic and related vaccines for canine and feline health.

Regional Insights

North America was the largest region in the companion animal vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Companion Animal Vaccines Market?

The companion animal vaccines market consists of sales of subunit vaccines, DNA vaccines, rabies vaccines, and distemper vaccines. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

What is the Market Assessment and Strategic Outlook for the Companion Animal Vaccines Industry?

The companion animal vaccines market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the companion animal vaccines industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

What is the Market Assessment and Strategic Outlook for the Companion Animal Vaccines Market Report 2026?

The companion animal vaccines market research report is one of a series of new reports from The Business Research Company that provides companion animal vaccines market statistics, including companion animal vaccines industry global market size, regional shares, competitors with a companion animal vaccines market share, detailed companion animal vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the companion animal vaccines industry. This companion animal vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.